5395242025-04-012025-06-305395242025-04-012025-06-30in-capmkt:OtherExpenses1Member5395242025-04-012025-06-30in-capmkt:OtherExpenses2Member5395242025-04-012025-06-30

ItemsThatWillNotBeReclassifiedToProfitAndLoss1

iso4217:INRiso4217:INRxbrli:shares

539524

LALPATHLAB

NOTLISTED

INE600L01024

Dr. Lal Path Labs Ltd.

Main Board

Equity

2025-04-01

2026-03-31

2025-07-31

2025-07-24

INR

Millions

Quarterly

First quarter

Single segment

The business of running laboratories for carrying out Pathological investigations of various branches of Bio-chemistry, Hematology, Histopathology, Microbiology, Electrophoresis, Immuno-chemistry, Immunology, Virology, Cytology, other pathological and radiological investigations.

2025-07-31

11:00:00

2025-07-31

13:15:00

Not applicable

2025-04-01

2025-06-30

Unaudited

Consolidated

6698000000

281000000

6979000000

1289000000

1323000000

47000000

346000000

2163000000

5168000000

1811000000

450000000

21000000

471000000

1340000000

-9000000

1331000000

1324000000

16000000

1315000000

16000000

838000000

15.88

15.85

15.88

15.85

Due to size constraint technical glitch we have not pasted complete notes to statement of financial results Please refer pdf file for complete notes to the statement of Financial Results for the quarter ended June 30 2025

Fees to collection centers/channel partners

922000000

Other expenses

1241000000

Remeasurement of the defined benefit obligations

-12000000

-3000000

-9000000